Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France.
INSERMU1153, Statistic and Epidemiologic Research Center Sorbonne Paris Cité (CRESS), ECSTRRA Team, Saint-Louis Hospital, Paris, France.
Stat Methods Med Res. 2020 Jun;29(6):1612-1623. doi: 10.1177/0962280219870217. Epub 2019 Aug 28.
Net survival is used in epidemiological studies to assess excess mortality due to a given disease when causes of death are unreliable. By correcting for the general population mortality, it allows comparisons between regions or periods and thus evaluation of health policies. The Pohar-Perme non-parametric estimator of net survival has been recently proposed, soon followed by an appropriate log-rank-type test. However, log-rank tests are known to be under-optimal in non-proportional settings (e.g. crossing of the hazard functions). In classical survival analysis, one solution is to compare the restricted mean survival times. A difference in restricted mean survival time represents a life benefit or loss over the studied period. In the present article the restricted mean net survival time was used to derive a specific test statistic to compare net survivals in proportional and non-proportional hazards settings. The new test was generalized to more than two groups and to stratified analysis. The test performance was assessed on simulation study, compared to the log-rank-type test, and its use illustrated on a population-based colorectal cancer registry. The new test for net survival comparisons proved robust to non-proportionality and well-performing in proportional hazards situations. Furthermore, it is also suited to the classical survival framework.
净生存分析用于流行病学研究,以评估由于给定疾病导致的死亡率过高,而当死因不可靠时。通过校正一般人群的死亡率,可以在地区或时期之间进行比较,从而评估卫生政策。Pohar-Perme 非参数净生存估计量最近被提出,随后很快就有了适当的对数秩检验。然而,在非比例情况下(例如,危险函数交叉),对数秩检验被认为是次优的。在经典的生存分析中,一种解决方案是比较受限平均生存时间。受限平均生存时间的差异代表了在研究期间的生存获益或损失。在本文中,使用受限平均净生存时间来推导出一个特定的检验统计量,以比较比例和非比例危险情况下的净生存。该新检验被推广到两个以上的组和分层分析。在模拟研究中评估了该检验的性能,并与对数秩检验进行了比较,还在基于人群的结直肠癌登记处进行了说明。用于净生存比较的新检验对非比例性具有稳健性,在比例危险情况下表现良好。此外,它也适用于经典的生存框架。